MesenFlow

Translational Solutions

[MesenFlow @MesenFlow]

Translational medicine in action, and validation for the MesenFlow strategy. Mesenchymal factors regulate human CD16+ monocyte function in chronic inflammation and cancer. https://t.co/fSnaphicE5

[Nature Communications @NatureComms]

Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
https://t.co/8rcTpefphF

[MesenFlow @MesenFlow]

MesenFlow Technologies is proud to be part of a study on circadian rhythms in leukocyte trafficking, published in @ImmunityCP. What a fantastic way to end the year.
We wish our friends and colleagues a Happy New Year for 2019!
https://t.co/k0V3AMvJHx

[MesenFlow @MesenFlow]

Commentary on the publication in Nature Comms, with the founders of MesenFlow Technologies. Applying powerful and deliverable translational technologies to cancer therapy. https://t.co/lmZM5jXzRy

[MesenFlow @MesenFlow]

Valdiating a translational approach in the treatment of cancer & chronic inflammation. A radio interview with author Adama Sidibe about a recent publication in Nature Comms. Further validation of the MesenFlow strategy (In French). https://t.co/FONS2e5AYN via @RadioTeleSuisse

[MesenFlow @MesenFlow]

@stuartacook1 Good to see you on Twitter. All a bit new to me. Maybe this link is of interest to you in CV disease and chronic inflammation? Regards, Paul https://t.co/fSnaphzNvD

[Nature Communications @NatureComms]

Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
https://t.co/8rcTpefphF

[Nature Communications @NatureComms]

Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
https://t.co/8rcTpefphF

[MesenFlow @MesenFlow]

I'm going to CPhI Worldwide, 24-26 Oct, Messe Frankfurt, Germany. Join me! https://t.co/QSBtsAurRq @CPhIWW #cphiww

[MesenFlow @MesenFlow]

Setting up our stand. MesenFlow Technologies is at the ESM-EVBO 2017 conference in Geneva. Looking forward to seeing you there!

[MesenFlow @MesenFlow]

MesenFlow will be at the ESM-EVBO 2017, May 29-June 1st 2017, Geneva, Switzerland https://t.co/hfE7CZJuiv

[MesenFlow @MesenFlow]

Our Services

[MesenFlow @MesenFlow]

Good news with Venture Kick! https://t.co/UGzBjA11Uf

[MesenFlow @MesenFlow]

Just setting up my Twitter. #myfirstTweet